203 related articles for article (PubMed ID: 34535767)
61. Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans.
Brydon L; Harrison NA; Walker C; Steptoe A; Critchley HD
Biol Psychiatry; 2008 Jun; 63(11):1022-9. PubMed ID: 18242584
[TBL] [Abstract][Full Text] [Related]
62. Chronic Vagus Nerve Stimulation Significantly Improves Quality of Life in Treatment-Resistant Major Depression.
Conway CR; Kumar A; Xiong W; Bunker M; Aaronson ST; Rush AJ
J Clin Psychiatry; 2018 Aug; 79(5):. PubMed ID: 30152645
[TBL] [Abstract][Full Text] [Related]
63. Gene expression signatures differentiating major depressive disorder from subsyndromal symptomatic depression.
Hu G; Yu S; Yuan C; Hong W; Wang Z; Zhang R; Wang D; Li Z; Yi Z; Fang Y
Aging (Albany NY); 2021 May; 13(9):13124-13137. PubMed ID: 33971621
[TBL] [Abstract][Full Text] [Related]
64. Molecular serum signature of treatment resistant depression.
Ruland T; Chan MK; Stocki P; Grosse L; Rothermundt M; Cooper JD; Arolt V; Bahn S
Psychopharmacology (Berl); 2016 Aug; 233(15-16):3051-9. PubMed ID: 27325393
[TBL] [Abstract][Full Text] [Related]
65. [The relation between depression and inflammation].
Fisker L; Köhler-Forsberg O; Hageman I
Ugeskr Laeger; 2018 May; 180(20):. PubMed ID: 29761778
[TBL] [Abstract][Full Text] [Related]
66. Caudate nucleus volumes and genetic determinants of homocysteine metabolism in the prediction of psychomotor speed in older persons with depression.
Naismith S; Hickie I; Ward PB; Turner K; Scott E; Little C; Mitchell P; Wilhelm K; Parker G
Am J Psychiatry; 2002 Dec; 159(12):2096-8. PubMed ID: 12450963
[TBL] [Abstract][Full Text] [Related]
67. Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: a report of OPERATION study.
Wu Z; Chen J; Yuan C; Hong W; Peng D; Zhang C; Cao L; Fang Y
J Affect Disord; 2013 Sep; 150(3):834-9. PubMed ID: 23570952
[TBL] [Abstract][Full Text] [Related]
68. A kynurenine pathway enzyme aminocarboxymuconate-semialdehyde decarboxylase may be involved in treatment-resistant depression, and baseline inflammation status of patients predicts treatment response: a pilot study.
Yilmaz NS; Sen B; Karadag RF; Aslan S; Ekmekci Ertek I; Bozkurt A; Cicek S; Bolu A; Ucar H; Kocak C; Cevik C; Bukan N
J Neural Transm (Vienna); 2022 Dec; 129(12):1513-1526. PubMed ID: 36334154
[TBL] [Abstract][Full Text] [Related]
69. C-Reactive Protein as a Possible Predictor of Trail-Making Performance in Individuals with Psychiatric Disorders.
Dalkner N; Reininghaus E; Schwalsberger K; Rieger A; Hamm C; Pilz R; Lenger M; Queissner R; Falzberger VS; Platzer M; Fellendorf FT; Birner A; Bengesser SA; Weiss EM; McIntyre RS; Mangge H; Reininghaus B
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33023087
[TBL] [Abstract][Full Text] [Related]
70. Inflammation Mediates Body Weight and Ageing Effects on Psychomotor Slowing.
Balter LJT; Higgs S; Aldred S; Bosch JA; Raymond JE
Sci Rep; 2019 Oct; 9(1):15727. PubMed ID: 31673089
[TBL] [Abstract][Full Text] [Related]
71. Mental rotation in unipolar major depression.
Rogers MA; Bradshaw JL; Phillips JG; Chiu E; Mileshkin C; Vaddadi K
J Clin Exp Neuropsychol; 2002 Feb; 24(1):101-6. PubMed ID: 11935428
[TBL] [Abstract][Full Text] [Related]
72. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?
Dodd S; Bauer M; Carvalho AF; Eyre H; Fava M; Kasper S; Kennedy SH; Khoo JP; Lopez Jaramillo C; Malhi GS; McIntyre RS; Mitchell PB; Castro AMP; Ratheesh A; Severus E; Suppes T; Trivedi MH; Thase ME; Yatham LN; Young AH; Berk M
World J Biol Psychiatry; 2021 Sep; 22(7):483-494. PubMed ID: 33289425
[TBL] [Abstract][Full Text] [Related]
73. Predictors of cognitive impairment in treatment-resistant depression.
Gregory E; Torres IJ; Ge R; Blumberger DM; Downar JH; Daskalakis ZJ; Lam RW; Vila-Rodriguez F
J Affect Disord; 2020 Sep; 274():593-601. PubMed ID: 32663992
[TBL] [Abstract][Full Text] [Related]
74. The association between cytokines and psychomotor speed in a spectrum of psychotic disorders: A longitudinal study.
Larsen JB; Reitan SK; Løberg EM; Rettenbacher M; Bruserud Ø; Larsen TK; Anda L; Bartz-Johannessen C; Johnsen E; Kroken RA
Brain Behav Immun Health; 2021 Dec; 18():100392. PubMed ID: 34877553
[TBL] [Abstract][Full Text] [Related]
75. Unraveling psychomotor slowing in bipolar disorder.
Morsel AM; Temmerman A; Sabbe B; Hulstijn W; Morrens M
Neuropsychobiology; 2015; 71(4):234-40. PubMed ID: 26277992
[TBL] [Abstract][Full Text] [Related]
76. The inflammatory marker GDF-15 is not independently associated with late-life depression.
Teunissen CE; Durieux-Lu S; Blankenstein MA; Oude Voshaar RC; Comijs HC
J Psychosom Res; 2016 Apr; 83():46-9. PubMed ID: 27020076
[TBL] [Abstract][Full Text] [Related]
77. Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals.
Mkrtchian A; Evans JW; Kraus C; Yuan P; Kadriu B; Nugent AC; Roiser JP; Zarate CA
Mol Psychiatry; 2021 Jul; 26(7):3292-3301. PubMed ID: 32929215
[TBL] [Abstract][Full Text] [Related]
78. Cognitive slowing in Alzheimer's disease and geriatric depression.
Nebes RD; Brady CB; Reynolds CF
J Gerontol; 1992 Sep; 47(5):P331-6. PubMed ID: 1512439
[TBL] [Abstract][Full Text] [Related]
79. The effects of atypical and conventional antipsychotics on reduced processing speed and psychomotor slowing in schizophrenia: a cross-sectional exploratory study.
Morrens M; Hulstijn W; Sabbe B
Clin Ther; 2008 Apr; 30(4):684-92. PubMed ID: 18498917
[TBL] [Abstract][Full Text] [Related]
80. Relationship between immunometabolic status and cognitive performance among major depression disorder patients.
Sánchez-Carro Y; de la Torre-Luque A; Portella MJ; Leal-Leturia I; Salvat-Pujol N; Massaneda C; de Arriba-Arnau A; Urretavizcaya M; Peretó M; Toll A; Martínez-Ruiz A; Ferreiros-Martinez R; Álvarez P; Soria V; López-García P
Psychoneuroendocrinology; 2022 Mar; 137():105631. PubMed ID: 34929555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
